Korsana Biosciences, Inc. (KRSA)
32.83
-2.16
(-6.17%)
USD |
NASDAQ |
Sep 21, 16:00
33.09
+0.26
(+0.79%)
After-Hours: 20:00
Korsana Biosciences Market Cap : 19.96M for Sept. 21, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Market Cap Data
| Date | Value |
|---|---|
| September 18, 2026 | 21.27M |
| September 17, 2026 | 20.50M |
| September 16, 2026 | 18.99M |
| September 15, 2026 | 19.50M |
| September 14, 2026 | 19.22M |
| September 11, 2026 | 19.40M |
| September 10, 2026 | 14.93M |
| September 09, 2026 | 15.93M |
| September 08, 2026 | 14.30M |
| September 04, 2026 | 18.09M |
| September 03, 2026 | 147.78M |
| September 02, 2026 | 134.67M |
| September 01, 2026 | 124.24M |
| August 31, 2026 | 109.64M |
| August 28, 2026 | 112.92M |
| August 27, 2026 | 118.88M |
| August 26, 2026 | 123.65M |
| August 25, 2026 | 119.18M |
| August 24, 2026 | 117.09M |
| August 21, 2026 | 115.90M |
| August 20, 2026 | 121.26M |
| August 19, 2026 | 123.05M |
| August 18, 2026 | 122.75M |
| August 17, 2026 | 120.07M |
| August 14, 2026 | 112.92M |
| Date | Value |
|---|---|
| August 13, 2026 | 116.50M |
| August 12, 2026 | 116.79M |
| August 11, 2026 | 106.36M |
| August 10, 2026 | 106.66M |
| August 07, 2026 | 106.36M |
| August 06, 2026 | 106.07M |
| August 05, 2026 | 105.77M |
| August 04, 2026 | 104.58M |
| August 03, 2026 | 103.98M |
| July 31, 2026 | 102.49M |
| July 30, 2026 | 104.28M |
| July 29, 2026 | 104.28M |
| July 28, 2026 | 104.28M |
| July 27, 2026 | 104.28M |
| July 24, 2026 | 104.28M |
| July 23, 2026 | 107.85M |
| July 22, 2026 | 108.15M |
| July 21, 2026 | 110.09M |
| July 20, 2026 | 108.75M |
| July 17, 2026 | 108.45M |
| July 16, 2026 | 109.05M |
| July 15, 2026 | 110.54M |
| July 14, 2026 | 114.11M |
| July 13, 2026 | 113.81M |
| July 10, 2026 | 114.26M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Climb Bio, Inc. | 782.57M |
| Q32 Bio, Inc. | 248.76M |
| Arrowhead Pharmaceuticals, Inc. | 9.710B |
| Oncolytics Biotech, Inc. | 95.71M |
| Sangamo Therapeutics, Inc. | 60.03M |
Market Cap Related Metrics
| PS Ratio | 9.566 |
| PEG Ratio | -0.0221 |
| Price to Book Value | 3.924 |
| Price | 32.83 |
| Earnings Yield | -35.82% |
| PEGY Ratio | -0.0221 |